. 2026 May 31;16(5):2823–2830. doi: 10.5455/OVJ.2026.v16.i5.24

Table 2. Effectiveness of MLE on sperm viability during chilled storage.

Treatment	Days
Treatment	1	2	3	4	5
T0	90.40 ± 2.07	76.50 ± 2.08^a	64.00 ± 4.97^a	51.50 ± 1.29^a	32.75 ± 2.22^a
T1	90.60 ± 1.52	79.75 ± 1.50^ab	71.50 ± 3.11^b	52.50 ± 3.11^a	34.50 ± 2.08^a
T2	90.80 ± 0.84	83.50 ± 1.29^b	75.25 ± 1.71^b	64.75 ± 2.22^b	51.00 ± 2.16^b
T3	90.00 ± 1.58	77.25 ± 2.50^ab	57.75 ± 4.19^a	51.25 ± 1.71^a	37.50 ± 3.51^a

Note: Values are presented as mean ± standard deviation (SD) based on six independent ejaculates (n = 6) per treatment per storage day. ^abDifferent superscript letters within the same colomn p < 0.05).; T0 (Control): 100% Andromed extender; T1 (MLE-2): 98% Andromed + 2% MLE; T2 (MLE-4): 96% Andromed + 4% MLE; T3 (MLE-6): 94% Andromed + 6% MLE.